Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLS-CARE for high-risk primary osteoporosis
jRCTs031250513Recruiting
- Sponsor
- Amgen
- Start
- Nov 2025
- Countries
- 1
01
Overview
Open-label trial in involutional osteoporosis (2 arms), sponsored by Amgen. Primary endpoint: Incidence rate of new vertebral fractures. Started Nov 2025; status: recruiting.
02
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCTs031250513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250513.